Month: March 2020

Record Quarterly Revenue of $37.8 Million – Earnings Per Share of $0.03Record Annual Revenue of $123.9 Million, a 95% Increase over 2018 Annual RevenueEWING, N.J., March 03, 2020 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”) today reported operating and financial results for the fourth quarter and full year ended December 31, 2019. The Company reported total revenue of $37.8 million for the fourth quarter of 2019 and $123.9 million for the year ended December 31, 2019. Net income per share was $0.03 for the fourth quarter of 2019 and a net loss per share of $0.01 for the year ended December 31, 2019.“Our evolution as a pharmaceutical technology company continued in 2019, as we delivered record revenue and the Company’s first full year of operating income. Our revenue of almost $124 million and first time...

LAFAYETTE, Louisiana, March 03, 2020 (GLOBE NEWSWIRE) — Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX: VMD.TO and NASDAQ:VMD), a home medical equipment supplier that provides post-acute respiratory care services in the United States, announced today that it has reported its financial results for the three months and year ended December 31, 2019.Operational highlights (all dollar amounts are USD):As previously disclosed, the Company now presents revenue net of bad debt expense. Net revenues for the quarter ended December 31, 2019 were $21.4 million, an increase of 30% over revenue less bad debt expense reported for the comparable quarter ended December 31, 2018. Net revenues for the year ended December 31, 2019 were approximately $80.3 million, an increase of 38% over revenue less bad debt expense reported for the prior...

MEMPHIS, Tenn., March 03, 2020 (GLOBE NEWSWIRE) — AutoZone, Inc. (NYSE: AZO) today reported net sales of $2.5 billion for its second quarter (12 weeks) ended February 15, 2020, an increase of 2.6% from the second quarter of fiscal 2019 (12 weeks).  Domestic same store sales, or sales for stores open at least one year, decreased 0.8% for the quarter.Operating profit increased 2.0% to $407.9 million. Net income for the quarter increased 1.6% over the same period last year to $299.3 million, while diluted earnings per share increased 7.8% to $12.39 per share from $11.49 per share in the year-ago quarter.For the quarter, gross profit, as a percentage of sales, increased to 54.3% (versus 54.1% the same period last year) primarily driven by supply chain leverage. Operating expenses, as a percentage of sales, were 38.1% (versus 37.7% the...

VIRGINIA CITY, Nev., March 03, 2020 (GLOBE NEWSWIRE) — Comstock Mining Inc. (“Comstock” or the “Company”) (NYSE American: LODE) today provided updates on key components of its strategic objectives, including with Mercury Clean Up LLC (“MCU”), Tonogold Resources Inc. (“Tonogold”) and Sierra Springs Opportunity Fund Inc. (“SSOF”).Strategic Transactions Advancing Value During 2019, the Comstock Board of Directors approved a transformational strategy focused on high-value, cash-generating, precious metal-based activities (the “Strategic Focus”), including, but not limited to, environmentally friendly and economically enhancing clean mining and processing technologies, precious-metal exploration, resource development, economic feasibility assessments and cash-generating mineral production.  The Company has made major advancements with...

– Record Fourth Quarter 2019 Revenues Increase 48% to $9.8 Million – 

MALVERN, Pa., March 03, 2020 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced its financial and operating results for the fourth quarter and full year of 2019.Fourth Quarter 2019 HighlightsFourth quarter 2019 revenue of $17.4 million, an increase of 11% over the fourth quarter of 2018Fourth quarter 2019 U.S. treatment session revenue of $11.2 million, an increase of 13% over the fourth quarter of 2018Fourth quarter 2019 U.S. NeuroStar® Advanced Therapy revenue of $5.4 million, an increase of 14% over the fourth quarter of 2018Active installed base was 1,085, as of December 31, 2019, an increase of 20% over the prior year periodFull...